The Canadian Nuclear Safety Commission has revoked Best Theratronics Ltd.’s Class IB licence after finding that the Ottawa manufacturer no longer carried on activities requiring it, while confirming that separate licensing would continue to govern its remaining nuclear material.

In its July 31, 2026 Record of Decision, DEC 26-H112, the Commission also determined that Order 7396415 ceased to have effect. That result did not free the company from nuclear regulation or authorize it to resume activities permitted only by the revoked licence.

Reduced inventory changed the licensing framework

The Class IB licence, which otherwise would have expired on June 30, 2029, authorized manufacturing activities involving cyclotrons and medical equipment, including cobalt-60 radiation-therapy units and cesium-137 blood irradiators.

A designated officer had issued Order 7396415 in November 2024. As most recently amended in February 2026, it required steps including shipping the Category 1 and Category 2 sources held under the Class IB licence and providing financial security for decommissioning.

The company then substantially reduced its sealed-source inventory. The decision records that approximately 86 per cent of its cobalt-60 inventory and 92 per cent of its cesium-137 inventory had been exported. That reduction moved the facility outside the Class IB framework.

On June 9, 2026, a designated officer issued a nuclear substances and radiation devices storage licence. It authorized possession, transfer, export and storage of the nuclear substances and prescribed equipment remaining onsite. It also included a financial-guarantee scheme and required Best Theratronics to maintain a letter of credit in favour of the CNSC, ensuring funding for decommissioning.

Revocation rather than waiting until 2029

Section 25 of the Nuclear Safety and Control Act allows the Commission to revoke a licence on its own initiative in prescribed circumstances. The applicable condition here was paragraph 8(2)(f) of the General Nuclear Safety and Control Regulations: the licensee no longer carries on the licensed activity.

The Commission considered written submissions from CNSC staff and the company, which had an opportunity to be heard. Staff reported that there was no operating cyclotron at the facility and that the company did not intend to operate one. Equipment onsite remained under assembly and conventional in nature.

Best Theratronics initially did not object to revocation, then suggested allowing the licence to expire. The Commission rejected that approach because the licence would remain valid until 2029. It found that the company was not carrying on any activity requiring a Class IB licence and would remain subject to CNSC oversight through its separate storage licence.

Why the existing order ended

The Commission treated the order’s seven conditions individually. Requirements concerning an inventory, shipping plan and monthly shipping reports had been satisfied, and a revised preliminary decommissioning plan had been provided within the required time.

Other conditions had become unnecessary with revocation and the transition to the new licensing framework. Remaining sources were no longer held under the Class IB licence. The financial-security requirement attached to that licence also ceased, but financial assurance and the letter-of-credit requirement continued under the new licence.

The decision therefore ended the particular order, whose actions related solely to the Class IB licence. It did not conclude that all nuclear substances had left the facility.

Cyclotron testing was not approved

After the proceeding’s deadlines had passed, Best Theratronics sought permission to conduct limited, low-power factory acceptance testing of a disassembled 70 MeV cyclotron. Staff understood that a prospective purchaser wanted the testing completed and identified additional regulatory steps that would be needed, including an amendment to the company’s Class II licence.

The Commission refused to consider that request because it fell outside this proceeding. It said the company should continue working with staff if it needed a limited, temporary exemption, and be prepared to demonstrate that the applicable risk requirements were met.

The Commission emphasized that revocation left Best Theratronics without authority to have a cyclotron capable of producing nuclear energy with a beam energy above 50 MeV at the facility. The company remained restricted to activities allowed by its still-valid licences; the ruling itself granted no testing exemption.